Parallel Advisors, LLC Procept Bio Robotics Corp Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,016 shares of PRCT stock, worth $70,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,016
Previous 577
76.08%
Holding current value
$70,378
Previous $46,000
76.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
41.4MCall Options Held
263KPut Options Held
201K-
Vanguard Group Inc Valley Forge, PA5.14MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$241 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$121 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$103 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$83.6 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.09B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...